Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityConvertible DebtCurrent AssetsCurrent Deferred RevenueCurrent LeasesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Integra Lifesciences Holdings (IART) Non-Current Assets (2016 - 2025)

Historic Non-Current Assets for Integra Lifesciences Holdings (IART) over the last 17 years, with Q3 2025 value amounting to $2.5 billion.

  • Integra Lifesciences Holdings' Non-Current Assets fell 1562.26% to $2.5 billion in Q3 2025 from the same period last year, while for Sep 2025 it was $10.9 billion, marking a year-over-year decrease of 340.98%. This contributed to the annual value of $3.0 billion for FY2024, which is 850.94% up from last year.
  • According to the latest figures from Q3 2025, Integra Lifesciences Holdings' Non-Current Assets is $2.5 billion, which was down 1562.26% from $2.5 billion recorded in Q2 2025.
  • In the past 5 years, Integra Lifesciences Holdings' Non-Current Assets ranged from a high of $3.0 billion in Q3 2024 and a low of $2.5 billion during Q3 2025
  • Moreover, its 5-year median value for Non-Current Assets was $2.7 billion (2021), whereas its average is $2.7 billion.
  • As far as peak fluctuations go, Integra Lifesciences Holdings' Non-Current Assets skyrocketed by 1604.46% in 2021, and later plummeted by 1562.26% in 2025.
  • Integra Lifesciences Holdings' Non-Current Assets (Quarter) stood at $2.6 billion in 2021, then grew by 3.79% to $2.7 billion in 2022, then fell by 0.16% to $2.7 billion in 2023, then increased by 8.51% to $3.0 billion in 2024, then decreased by 15.32% to $2.5 billion in 2025.
  • Its last three reported values are $2.5 billion in Q3 2025, $2.5 billion for Q2 2025, and $2.9 billion during Q1 2025.